Quiverquant

Published September 22, 2026

Optimi Health Corp. Appoints Michael Blough as Chief Clinical Development Officer to ...

Read the full story at Quiverquant

psychedelic therapies. With extensive experience ... "Michael brings to Optimi a valuable combination of clinical trial expertise in psychedelics.